Cargando…

Limited Joint Mobility Progression in Type 1 Diabetes: A 15-Year Follow-Up Study

OBJECTIVE: To assess the evolution of joint mobility over a period of 15 years in type 1 diabetic patients and healthy controls and to determine whether microalbuminuria is associated with a different evolution of joint mobility. METHODS: Joint mobility of hand and wrist was determined in 63 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Labad, Javier, Rozadilla, Antoni, Garcia-Sancho, Paula, Nolla, Joan M., Montanya, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954902/
https://www.ncbi.nlm.nih.gov/pubmed/29853876
http://dx.doi.org/10.1155/2018/1897058
_version_ 1783323610891419648
author Labad, Javier
Rozadilla, Antoni
Garcia-Sancho, Paula
Nolla, Joan M.
Montanya, Eduard
author_facet Labad, Javier
Rozadilla, Antoni
Garcia-Sancho, Paula
Nolla, Joan M.
Montanya, Eduard
author_sort Labad, Javier
collection PubMed
description OBJECTIVE: To assess the evolution of joint mobility over a period of 15 years in type 1 diabetic patients and healthy controls and to determine whether microalbuminuria is associated with a different evolution of joint mobility. METHODS: Joint mobility of hand and wrist was determined in 63 patients with type 1 diabetes and 63 healthy subjects. Fifteen years later, 37 (58.7%) diabetic patients and 16 (25.4%) healthy subjects were studied again. Joint mobility was assessed with the Prayer sign and by measuring the angle of maximal flexion of the fifth and third metacarpophalangeal (MCP) joints and wrist. Patients with diabetes were visited 2–4 times every year with regular assessment of glycated hemoglobin (HbA1(c)), urinary albumin excretion (UAE), and ophthalmoscopy. RESULTS: Fifteen years after the initial exam, diabetic patients showed reduced flexion of the fifth MCP joint (82.6 ± 5.8 versus 76.0 ± 6.4 degrees, p < 0.001) and wrist (75.9 ± 8.1 versus 73.2 ± 7.4 degrees, p = 0.015) compared to baseline examination. Joint mobility did not change significantly in healthy subjects. Patients with microalbuminuria showed greater reduction in hand joint mobility than diabetic patients with normal UAE or than healthy subjects (p < 0.001). CONCLUSIONS: In type 1 diabetic patients, the severity of LJM progresses with time, and the progression is enhanced in patients with microalbuminuria.
format Online
Article
Text
id pubmed-5954902
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59549022018-05-31 Limited Joint Mobility Progression in Type 1 Diabetes: A 15-Year Follow-Up Study Labad, Javier Rozadilla, Antoni Garcia-Sancho, Paula Nolla, Joan M. Montanya, Eduard Int J Endocrinol Research Article OBJECTIVE: To assess the evolution of joint mobility over a period of 15 years in type 1 diabetic patients and healthy controls and to determine whether microalbuminuria is associated with a different evolution of joint mobility. METHODS: Joint mobility of hand and wrist was determined in 63 patients with type 1 diabetes and 63 healthy subjects. Fifteen years later, 37 (58.7%) diabetic patients and 16 (25.4%) healthy subjects were studied again. Joint mobility was assessed with the Prayer sign and by measuring the angle of maximal flexion of the fifth and third metacarpophalangeal (MCP) joints and wrist. Patients with diabetes were visited 2–4 times every year with regular assessment of glycated hemoglobin (HbA1(c)), urinary albumin excretion (UAE), and ophthalmoscopy. RESULTS: Fifteen years after the initial exam, diabetic patients showed reduced flexion of the fifth MCP joint (82.6 ± 5.8 versus 76.0 ± 6.4 degrees, p < 0.001) and wrist (75.9 ± 8.1 versus 73.2 ± 7.4 degrees, p = 0.015) compared to baseline examination. Joint mobility did not change significantly in healthy subjects. Patients with microalbuminuria showed greater reduction in hand joint mobility than diabetic patients with normal UAE or than healthy subjects (p < 0.001). CONCLUSIONS: In type 1 diabetic patients, the severity of LJM progresses with time, and the progression is enhanced in patients with microalbuminuria. Hindawi 2018-05-02 /pmc/articles/PMC5954902/ /pubmed/29853876 http://dx.doi.org/10.1155/2018/1897058 Text en Copyright © 2018 Javier Labad et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Labad, Javier
Rozadilla, Antoni
Garcia-Sancho, Paula
Nolla, Joan M.
Montanya, Eduard
Limited Joint Mobility Progression in Type 1 Diabetes: A 15-Year Follow-Up Study
title Limited Joint Mobility Progression in Type 1 Diabetes: A 15-Year Follow-Up Study
title_full Limited Joint Mobility Progression in Type 1 Diabetes: A 15-Year Follow-Up Study
title_fullStr Limited Joint Mobility Progression in Type 1 Diabetes: A 15-Year Follow-Up Study
title_full_unstemmed Limited Joint Mobility Progression in Type 1 Diabetes: A 15-Year Follow-Up Study
title_short Limited Joint Mobility Progression in Type 1 Diabetes: A 15-Year Follow-Up Study
title_sort limited joint mobility progression in type 1 diabetes: a 15-year follow-up study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954902/
https://www.ncbi.nlm.nih.gov/pubmed/29853876
http://dx.doi.org/10.1155/2018/1897058
work_keys_str_mv AT labadjavier limitedjointmobilityprogressionintype1diabetesa15yearfollowupstudy
AT rozadillaantoni limitedjointmobilityprogressionintype1diabetesa15yearfollowupstudy
AT garciasanchopaula limitedjointmobilityprogressionintype1diabetesa15yearfollowupstudy
AT nollajoanm limitedjointmobilityprogressionintype1diabetesa15yearfollowupstudy
AT montanyaeduard limitedjointmobilityprogressionintype1diabetesa15yearfollowupstudy